, , , ,
doi.org/10.1007/s002800050727, hdl.handle.net/1765/64889
Cancer Chemotherapy and Pharmacology
Department of Medical Oncology

Ma, J, Maliepaard, M, Kolker, H.J, Verweij, J, & Schellens, J.H.M. (1998). Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1. Cancer Chemotherapy and Pharmacology, 41(3), 186–192. doi:10.1007/s002800050727